KATHMANDU, Dec 25: The government has started administering Johnson & Johnson vaccines from various hospitals in Kathmandu giving priority to those going abroad for work.

LONDON, Sept 22: Johnson & Johnson said Tuesday that a booster of its one-shot coronavirus vaccine provides a stronger immune response months after people receive a first dose.

With boosters being planned in the U.S. as early as the fall for those who got the two-shot Pfizer and Moderna vaccines, recipients of the single-dose J&J jab might be wondering just how well their protection is holding up.

KATHMANDU, July 10: The 1.5 million doses of Johnson and Johnson COVID-19 vaccines that the US is providing under the COVAX facility is set to arrive in Nepal on Monday morning.

WASHINGTON, July 9: The United States on Friday will send 1.5 million doses of the Johnson & Johnson COVID-19 vaccine to Nepal and 500,000 doses of the Moderna vaccine to Bhutan, a White House official said.

WASHINGTON, Feb 28: The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.

Aug 26: An Oklahoma judge on Monday will decide whether Johnson & Johnson should be held liable in a $17 billion lawsuit alleging the drugmaker’s marketing practices fueled the opioid epidemic by causing a flood of painkillers in the market.

Feb 14: A key supplier of talc used in Johnson & Johnson’s baby powder filed for Chapter 11 bankruptcy on Wednesday in the wake of multibillion-dollar lawsuits alleging its products caused ovarian cancer and asbestos-related mesothelioma.

NEW YORK, Dec 18: Johnson & Johnson on Monday scrambled to contain fallout from a Reuters report that the healthcare conglomerate knew for decades that cancer-causing asbestos lurked in its Baby Powder, taking out full-page newspaper ads defending its product and practices, and readying its chief executive for his first television interview since investors erased tens of billions of dollars from the company’s market value.

(Reuters) - Shares of Johnson & Johnson (JNJ.N) fell 10 percent on Friday and were on track to post their biggest percentage drop in more than 16 years, after Reuters reported that the pharma major knew for decades that cancer-causing asbestos lurked in its Baby Powder.

CALIFORNIA, Nov 16: A California jury has cleared US pharmaceutical giant Johnson & Johnson (J&J) of liability in a case involving a woman who alleged that the company’s talc-based products contain asbestos and caused her cancer.